10 : 3010 : 54 1F Annex 1! 1 15:3015 : 58 1F Annex 1

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "10 : 3010 : 54 1F Annex 1! 1 15:3015 : 58 1F Annex 1"

Transcription

1 :0010 : 24 1F Annex 1! 2 15:0015 : 24 1F Annex 1!!

2 10 : 3010 : 54 1F Annex 1! 1 15:3015 : 58 1F Annex 1

3 ! 2 10:0010 : 28 1F Annex 1

4 3 15:0015 : 28 1F Annex :3010 : 58 1F Annex 1

5 1 15:3015 : 58 1F Annex 1! 2 10:0010 : 28 1F Annex 1

6 !! 3 15:0015 : 28 1F Annex 1!!!κ!γ

7 1 10:3010 : 54 1F Annex :3015 : 54 1F Annex 1!!!!!

8 1 15:0015 : 24 1F Annex :0010 : 24 1F Annex 1!

9 3 15:3015 : 50 1F Annex :0015 : 24 1F Annex 1! β!

10 μ! 2 10:3010 : 50 1F Annex 1 GNR1 15 : 3015 : 58 1F Annex 1 "β" β

11 !! β! GNR2 10 : 0010 : 28 1F Annex 1 β

12 1 15:0015 : 20 1F Annex :3010 : 50 1F Annex 1

13 1 15:3015 : 54 1F Annex :0010 : 28 1F Annex 1!

14 1 15:3015 : 50 1F Annex 1! 2 10:3010 : 50 1F Annex :0015 : 28 1F Annex 1

15 2 10:0010 : 28 1F Annex 1

16 1 15:3015 : 54 1F Annex :3010 : 54 1F Annex 1

17 3 15:0015 : 24 1F Annex :0010 : 24 1F Annex 1!!

18

19 :0010 : 24 1F Annex :0013 : 24 1F Annex 1

20 7 10:3010 : 50 1F Annex : 3013 : 50 1F Annex 1!

21 1 10:0010 : 24 1F Annex :0013 : 20 1F Annex 1

22 1 10:3010 : 50 1F Annex :3013 : 46 1F Annex 1

23 10 : 0010 : 24 1F Annex 1! " 13 : 0013 : 28 1F Annex 1

24 10 : 3010 : 54 1F Annex 1 13 : 3013 : 58 1F Annex 1

25 1 10:0010 : 24 1F Annex 1 β!!

26 2 13:0013 : 28 1F Annex 1! 1 10:3010 : 54 1F Annex 1

27 2 13:3013 : 54 1F Annex :0010 : 20 1F Annex 1

28 4 13:0013 : 24 1F Annex 1!

29 HIV1 13 : 3013 : 58 1F Annex 1 HIV2 10 : 3010 : 58 1F Annex 1!

30 !! HIV3 13 : 0013 : 28 1F Annex 1!

31 13 : 3013 : 50 1F Annex :0010 : 20 1F Annex 1 μ! κ

32 2 13:0013 : 20 1F Annex :3010 : 54 1F Annex 1!

33 2 13:3013 : 54 1F Annex :0010 : 28 1F Annex 1

34 4 13:0013 : 24 1F Annex 1 β 1 10:3010 : 50 1F Annex 1!

35 2 13:3013 : 46 1F Annex :0010 : 20 1F Annex 1

36

第86回日本感染症学会総会学術集会後抄録(I)

第86回日本感染症学会総会学術集会後抄録(I) κ κ κ κ κ κ μ μ β β β γ α α β β γ α β α α α γ α β β γ μ β β μ μ α ββ β β β β β β β β β β β β β β β β β β γ β μ μ μ μμ μ μ μ μ β β μ μ μ μ μ μ μ μ μ μ μ μ μ μ β

More information

研修コーナー

研修コーナー l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l

More information

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-7 O1-8 O1-9 O1-10 O1-11 O1-12 O1-13 O1-14 O1-15 O1-16 O1-17 O1-18 O1-19 O1-20 O1-21 O1-22 O1-23 O1-24 O1-25 O1-26 O1-27 O1-28 O1-29 O1-30 O1-31 O1-32 O1-33 O1-34 O1-35

More information

nsg02-13/ky045059301600033210

nsg02-13/ky045059301600033210 φ φ φ φ κ κ α α μ μ α α μ χ et al Neurosci. Res. Trpv J Physiol μ μ α α α β in vivo β β β β β β β β in vitro β γ μ δ μδ δ δ α θ α θ α In Biomechanics at Micro- and Nanoscale Levels, Volume I W W v W

More information

- 1 -

- 1 - - 1 - HIV cmc cmc - 2 - cmc() ( ) 5-3 - - 4 - (1) (2) (3) ( ) - 5 - 0537-73-2662 0537-35-2971 0548-63-1251 9 00 16 00-6 - - 7 - 2 3 4 5 6 1,328 1,848 2,368 2,888 3,408-8 - - 9 - - 10 - - 11 - 3-12 - (

More information

日歯雑誌(H28・8月号)別刷り/ポスターセッション とびら

日歯雑誌(H28・8月号)別刷り/ポスターセッション とびら α P. gingivalis P. gingivalis αsmatgf- VEGF-A α in vitro μ Porphyromonas gingivalis in vitro Porphyromonas gingivalis β β β JBiolChem. μ μ μ β Porphyromonas gingivalis in vitro μ α β α

More information

JFC11j-kokumin_SKM-Master.indd

JFC11j-kokumin_SKM-Master.indd 13 13 1634 1 22 271 144 13 118 216 1 634 3,512 8,19 (1 2 3 () 4 994 22 2 4.4% 119 8.6% 59 21.1% 4 65.9% () 1 7.4% 1 5.% 42.6% () 83 7 22 318,94 22 27.8% 77.% () 1 2 15.3% 23.% 318,94 22 76.3% () 1 2 23.7%

More information

3/4/8:9 { } { } β β β α β α β β

3/4/8:9 { } { } β β β α β α β β α β : α β β α β α, [ ] [ ] V, [ ] α α β [ ] β 3/4/8:9 3/4/8:9 { } { } β β β α β α β β [] β [] β β β β α ( ( ( ( ( ( [ ] [ ] [ β ] [ α β β ] [ α ( β β ] [ α] [ ( β β ] [] α [ β β ] ( / α α [ β β ] [ ] 3

More information

日本医科大学医学会雑誌第8巻第1号

日本医科大学医学会雑誌第8巻第1号 Xenopus laevis in situ μ μ Xenopus laevis Xenopus laevis Xenopus laevis UGT1A1 UGT1A1 IL28B KRAS UGT1A1 UGT1A128 UGT UGT1A1 UGT1A128 UGT1A1 286 UGT1A1 UGT1A1 28 6 UGT UGT UGT1A128 UGT IL28B UGT1A1

More information

研修コーナー

研修コーナー l l l l l l l Department of Obstetrics and Gynecology, Fukui Medical University, Fukui l l l l l l µ l β β l α l µ µ l l l l Department of Obstetrics and Gynecology, Gifu University School of Medicine,

More information

nsg04-28/ky208684356100043077

nsg04-28/ky208684356100043077 δ!!! μ μ μ γ UBE3A Ube3a Ube3a δ !!!! α α α α α α α α α α μ μ α β α β β !!!!!!!! μ! Suncus murinus μ Ω! π μ Ω in vivo! μ μ μ!!! ! in situ! in vivo δ δ !!!!!!!!!! ! in vivo Orexin-Arch Orexin-Arch !!

More information

日本分子第5巻2号_15特別講演・シンポジウム.indd

日本分子第5巻2号_15特別講演・シンポジウム.indd 25 JSMI Report JSMI Report 26 41 JSMI Report JSMI Report 42 JSMI Report 54 55 JSMI Report JSMI Report 56 57 JSMI Report JSMI Report 58 59 JSMI Report JSMI Report 60 61 JSMI Report β JSMI Report 62 63 JSMI

More information

感染症学雑誌第77巻第8号

感染症学雑誌第77巻第8号 1 2 µ Streptococcus pneumoniae µ S. pneumoniae µ S. pneumoniae pbp β β pbp1a pbp2x pbp2b pbp mefe ermb pbp pbp1a pbp2x pbp2b pbp pbp pbp pbp 2x pbp1a pbp2x pbp 2b mefe ermb pbp β pbp2x β β β µ µ pbp3 µ

More information

1 1 1 2 2 3 3 4 5 6 6 7 8 8 8 9 10 10 14 16 17 17 18 18 18 23 27 27 27 28 29 29 30 30 31 32 32 33 34 34 35 36 37 38 38

1 1 1 2 2 3 3 4 5 6 6 7 8 8 8 9 10 10 14 16 17 17 18 18 18 23 27 27 27 28 29 29 30 30 31 32 32 33 34 34 35 36 37 38 38 2007 2006 11 29 1 1 1 2 2 3 3 4 5 6 6 7 8 8 8 9 10 10 14 16 17 17 18 18 18 23 27 27 27 28 29 29 30 30 31 32 32 33 34 34 35 36 37 38 38 40 40 40 11 41 41 42 42 43 43 44 45 46 46 47 47 49 50 51 51 52 53

More information

内科96巻3号★/NAI3‐1(第22回試験問題)

内科96巻3号★/NAI3‐1(第22回試験問題) µ µ α µ µ µ µ µ µ β β α γ µ Enterococcus faecalis Escherichia coli Legionella pneumophila Pseudomonas aeruginosa Streptococcus viridans α β 正解表正解記号問題 No. 正解記号問題 No. e(4.5) 26 e 1 a(1.2) 27 a 2

More information

( )

( ) ) ( ( ) 3 15m t / 1.9 3 m t / 0.64 3 m ( ) ( ) 3 15m 3 1.9m / t 0.64m 3 / t ) ( β1 β 2 β 3 y ( ) = αx1 X 2 X 3 ( ) ) ( ( ) 3 15m t / 1.9 3 m 3 90m t / 0.64 3 m ( ) : r : ) 30 ( 10 0.0164

More information

函館市_絵で見てわかる

函館市_絵で見てわかる 70 75 26 2 27 1 2 3 4 5 6 7 8 9 4 6 6 6 8 10 10 10 10 12 21 21 22 26 28 30 32 34 36 2 3 70 75 701 28 75 6575 7075 28 75 3 4 5 75 65 26 28 75 65 75 1 1 70 7075 2 2 2 1 260 90 210 18 9012 160 18 100 183

More information

TEL-E7

TEL-E7 Ni-Cd TEL-E7 TEL-EW7 2 3 4 5 6 7 8 9 0 2 3 4 5 6 7 8 9 20 Ni-Cd 2 3 2 2 3 22 2 2 3 4 3 4 23 2 2 3 3 24 25 2 3 4 2 3 4 26 2 3 2 3 27 2 2 2 28 2 2 2 29 2 3 2 4 30 2 2 3 3 2 3 2 3 3 32 33 2 3 34 2 3 35

More information

> > <., vs. > x 2 x y = ax 2 + bx + c y = 0 2 ax 2 + bx + c = 0 y = 0 x ( x ) y = ax 2 + bx + c D = b 2 4ac (1) D > 0 x (2) D = 0 x (3

> > <., vs. > x 2 x y = ax 2 + bx + c y = 0 2 ax 2 + bx + c = 0 y = 0 x ( x ) y = ax 2 + bx + c D = b 2 4ac (1) D > 0 x (2) D = 0 x (3 13 2 13.0 2 ( ) ( ) 2 13.1 ( ) ax 2 + bx + c > 0 ( a, b, c ) ( ) 275 > > 2 2 13.3 x 2 x y = ax 2 + bx + c y = 0 2 ax 2 + bx + c = 0 y = 0 x ( x ) y = ax 2 + bx + c D = b 2 4ac (1) D >

More information

- 2 -

- 2 - - 1 - RI Martin D. Kamen P450 MD Kamen Vanderbilt Howard Gest Indiana 32 P J. Biol. Chem., 1948 15N - 2 - - 3 - ATP ATP-DnaA/oriC DnaB DnaC DnaG DNA III B (pol III* + β ) G B G pol III* β - 4 - β Hda A

More information

長崎県県央保健所事業概要

長崎県県央保健所事業概要 P1 P2~P3 P4 P5 P7~P10 P11~P40 P41~P174 P175~P179 P181~P212 271,417 2 3 4 5 5 7 8 9 10 12 13 14 15 16 18 19 2,506 365 293 5 20 2 4 123 4 17 1 2 143 351 5 3 18 40 10 475 3 2 22 22 66 1 13 18 31 10

More information

447号.indd

447号.indd Eubalaena australis ( 2006 2,400 6.4% 1993-2008 1,2 1997 69 - - 2 2003 3,400 7.3% 1971-2003 2 1995 137 - - 2 1997 2,577 6.9% 1971-1990 2 1997 7,500 - - 2 1: IWC (2009). IWC/61/REP 1 (Annex H). 2: IWC (2009).

More information

gr09.dvi

gr09.dvi .1, θ, ϕ d = A, t dt + B, t dtd + C, t d + D, t dθ +in θdϕ.1.1 t { = f1,t t = f,t { D, t = B, t =.1. t A, tdt e φ,t dt, C, td e λ,t d.1.3,t, t d = e φ,t dt + e λ,t d + dθ +in θdϕ.1.4 { = f1,t t = f,t {

More information

喘息について\(公健協会宛02-5作成\)

喘息について\(公健協会宛02-5作成\) Q & A Q & A 1.? 20 2. 1) 2) 3) 4) 5) 6) 7) 1) 2) 3) 4) 5) 6) 7) 8) 9) 3. NHK ( ) 4 10 1 200mg ( ) ( 1 ) 4. ( ) ( ) 5. ( ) ( ) 6. β 2 ( ) 7. ( ) 1 8. 1. 2. 3. 4. 5. 6. 7. 8. 9. 2 5 7 1. 1 10 1) 2) 3) 30

More information

untitled

untitled c OR 21 OR 1. 21 21 IoT OR OR OR 260 8672 1 8 1 OR 2. 2.1 public health [1] communicable (infectious) diseases vehicle burden HIV/AIDS (SARS) 258 60 Copyright c by ORSJ. Unauthorized reproduction of this

More information

CVMに基づくNi-Al合金の

CVMに基づくNi-Al合金の CV N-A (-' by T.Koyama ennard-jones fcc α, β, γ, δ β α γ δ = or α, β. γ, δ α β γ ( αβγ w = = k k k ( αβγ w = ( αβγ ( αβγ w = w = ( αβγ w = ( αβγ w = ( αβγ w = ( αβγ w = ( αβγ w = ( βγδ w = = k k k ( αγδ

More information

13 6 2 68 34 JIS S0026 JIS JIS S0026 50000 2550mm 2550mm 2550mm 12 1 4 15 ( ) 3000 1 1 H17 ttp://www.isuzu.co.jp/product/bus/gala_ss/approach.html

More information

untitled

untitled .m 5m :.45.4m.m 3.m.6m (N/mm ).8.6 σ.4 h.m. h.68m h(m) b.35m θ4..5.5.5 -. σ ta.n/mm c 3kN/m 3 w 9.8kN/m 3 -.4 ck 6N/mm -.6 σ -.8 3 () :. 4 5 3.75m :. 7.m :. 874mm 4 865mm mm/ :. 7.m 4.m 4.m 6 7 4. 3.5

More information

90 NPO NPO NPO NPO NPO NPO

90 NPO NPO NPO NPO NPO NPO 89 NPO NPO NPO 90 NPO NPO NPO NPO NPO NPO 91 m 92 NPO 93 94 NPO 95 96 NPO In Japan, Buddhism May Be Dying Out Dying Out Dying Out 97 98 NPO ips 99 ISM 100 NPO NPO HIV NGO NPO HIV HIV km 101 HIV HIV HIV

More information

[ ] = L [δ (D ) (x )] = L D [g ] = L D [E ] = L Table : ħh = m = D D, V (x ) = g δ (D ) (x ) E g D E (Table )D = Schrödinger (.3)D = (regularization)

[ ] = L [δ (D ) (x )] = L D [g ] = L D [E ] = L Table : ħh = m = D D, V (x ) = g δ (D ) (x ) E g D E (Table )D = Schrödinger (.3)D = (regularization) . D............................................... : E = κ ............................................ 3.................................................

More information

<95F18D908F91967B95B62E696E6464>

<95F18D908F91967B95B62E696E6464> 1.. (1-1)? 1. 2.,,.. (1-2)? 1. 2. 3. 4. 5. 6. 7. (1-3)?. (() ().) 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. (: ) (1-4). 1. 2. 3. 4. 5. 6. 7. ( ) (1-5)?. 1. 2. 3. (1-6)?. 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. - 0

More information

.\ /......

.\ /...... 教育 研究 社会貢献活動報告 香 川 医 科 大 学 平成1 3年度 香川医科大学自己点検評価委員会 γ α β β β α β β γ γ α β αβ µ Anopheles Bolbosoma Leishmania Pneumocystis carinii P. carinii Bolbosoma Leishmania Anopheles Plasmodium

More information

C p (.2 C p [[T ]] Bernoull B n,χ C p p q p 2 q = p p = 2 q = 4 ω Techmüller a Z p ω(a a ( mod q φ(q ω(a Z p a pz p ω(a = 0 Z p φ Euler Techmüller ω Q

C p (.2 C p [[T ]] Bernoull B n,χ C p p q p 2 q = p p = 2 q = 4 ω Techmüller a Z p ω(a a ( mod q φ(q ω(a Z p a pz p ω(a = 0 Z p φ Euler Techmüller ω Q p- L- [Iwa] [Iwa2] -Leopoldt [KL] p- L-. Kummer Remann ζ(s Bernoull B n (. ζ( n = B n n, ( n Z p a = Kummer [Kum] ( Kummer p m n 0 ( mod p m n a m n ( mod (p p a ( p m B m m ( pn B n n ( mod pa Z p Kummer

More information

表1表4.indd

表1表4.indd The Journal of The Toyaku CONTENTS Vol.31 No.3 March 2009 出版委員会の活動について Vol 31No.32009 Vol 31No.32009 Vol 31No.32009 Vol 31No.32009 Vol 31No.32009 Vol 31No.32009 Vol 31No.32009 Vol 31No.32009 Vol 31No.32009

More information

2011 2014 19 22-1 - - 2 - - 3 - - 4 - HIV HIV - 5 - SCU - 6 - ICUHCU NICU NICU HCU NICU ALSO - 7 - T-MRI FISH - 8 - ME NST - 9 - - 10 - da Vinci C C C DPC - 11 - C C C C C C - 12 - C C D D DPC D D - 13

More information

日医雑誌第126巻第9号

日医雑誌第126巻第9号 [] HIV 4 sexually transmitted diseases 1975 WHO 12 3 2 5 3 1 1 4 3 40 1 1947 4 WHO 1975 STDsexually transmitted diseases STIsexually transmitted infection 5 STD 5 10 20 5 5 HIV STD RTIreproductive tract

More information

_FH28_J.qxd

_FH28_J.qxd 23.9 + + ø ø ø ø ø ø ø ø ø ++ + ++ + + + ± FH 28 D - 5 (25) S B -.5 SH (5) 2 3 4 5 6 7 8 9 2 6 7 3 8 4 9 5 ** ** ** ** ** ** ** ** ** ** ** ** ** CL586-86-4-** CL586-868-3-** CL586-823-5-** CL586-835-4-**

More information

t sex N y y y Diff (1-2)

t sex N y y y Diff (1-2) Armitage 1 1.1 2 t 1.2 SAS Proc GLM 2 2.1 1 1 2.1.1 50 1 1 t sex N y 50 116.45 119.6 122.75 11.071 1.5657 93.906 154.32 y 50 127.27 130.7 134.13 12.072 1.7073 102.68 163.37 y Diff (1-2) -15.7-11.1-6.504

More information

- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - 20log10 150 = 44 20log10 150 = 44-7 - - 8 - - 9 - - 10 - L ks X n + X 2 2 ) ( 1) ( 1 = X X n S n n n X L k k n X n X S n L n k - 11 - - 12 - - 13 - - 14 - - 15 - - 16

More information

Japan Research Review 1998年7月号

Japan Research Review 1998年7月号 Japan Research Review 1998.7 Perspectives ****************************************************************************************** - 1 - Japan Research Review 1998.7-2 - Japan Research Review 1998.7-3

More information

基本 CMYK

基本 CMYK Lawyer's Newsletter Miyako Law Off ice 42 Vol. 2015 Winter http://www.miyako-law.gr.jp/ 201542 2015 1 1 604-8106 8 TEL0752114433FAX0752212004 690-0884 62-6 3 TEL0852234300FAX0852324811 2H-A 2020 100 1

More information

... 1... 2... 3... 5... 6... 6... 6... 7... 8... 9... 10... 10...11... 12... 13... 14... 15... 15... 16... 17... 18... 19... 19... 20... 21... 22... 23... 24... 25... 25... 26... 27... 28... 29... 29...

More information

Доклад о мировых инвестициях 2009 года

Доклад о мировых инвестициях 2009 года 13 13 131 71 71 71 71 71 7 1 7 1 71 71 71 7, 2009 1 71 71 7 1 71 71 7 1 71 71 7, 1 71 71 71 71 71 7 1 71 71 71 71 7 1 7 1 7 1 71 71 71 71 7 13 131 71 71 7 1 7 1 7 1 71 71 71 7 1 71 71 71 71 7 1 71 71 71

More information

橡博論表紙.PDF

橡博論表紙.PDF Study on Retaining Wall Design For Circular Deep Shaft Undergoing Lateral Pressure During Construction 2003 3 Study on Retaining Wall Design For Circular Deep Shaft Undergoing Lateral Pressure During Construction

More information

untitled

untitled V. 8 9 9 8.. SI 5 6 7 8 9. - - SI 6 6 6 6 6 6 6 SI -- l -- 6 -- -- 6 6 u 6cod5 6 h5 -oo ch 79 79 85 875 99 79 58 886 9 89 9 959 966 - - NM /6 Nucl Ml SI NM/6/685 85co /./ /h / /6/.6 / /.6 /h o NM o.85

More information

現代物理化学 1-1(4)16.ppt

現代物理化学 1-1(4)16.ppt (pdf) pdf pdf http://www1.doshisha.ac.jp/~bukka/lecture/index.html http://www.doshisha.ac.jp/ Duet -1-1-1 2-a. 1-1-2 EU E = K E + P E + U ΔE K E = 0P E ΔE = ΔU U U = εn ΔU ΔU = Q + W, du = d 'Q + d 'W

More information

M.D.I VDT 29. (1)

M.D.I VDT 29. (1) 5. 5. 5.1 (1 (2 (3 (4 3040 5.2 32 1 1 43 2 44 3 45 13 14 1) 4 45 2 5 46 6 47 7 66 2 8 26 2 1 32 2) 1 2 53 3 39 4 40 5 56 6 29 7 38 8 22 9 22 3 48 2 29 5. 17 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14.

More information

2/11 ANNEX 2006.09.14 2 HATS HATS

2/11 ANNEX 2006.09.14 2 HATS HATS 1/11. HATS 2/11 ANNEX 2006.09.14 2 HATS HATS 3/11... 4... 5... 5... 6... 6... 6... 7 4/11 Annex SMTP CIAJ SMTP CIAJ 5/11 SMTP SMTP POP3 SMTP Annex 6/11 SMTP ESMTP POP IMAP4 RCPT TO 7/11 CPU SMTP CPU TCP/IP

More information

住宅ローンのリスク管理

住宅ローンのリスク管理 NSSOL & CPC 2008 (p.23) Credit Pricing Corp. @ Now Printing PD i 1 i 2 t = 1 α t Now Printing T i i i 1 1 2 2 n n T exp( βx ) βx = β x + β x + Lβ x x i DTI x i Now Printing Now Printing Now Printing

More information

元素戦略アウトルック 材料と全面代替戦略

元素戦略アウトルック 材料と全面代替戦略 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 23 2.2.4 スカンジウム ジウム内包フラーレンに関する研究 などがある スカンジウムはレアメタルの中でも特に希少な金属で 製 錬のプロセス技術を確立すること自体が研究課題である プ ロセスに関する研究は東京大で行われている その他 スカンジウム錯体を用いた触媒への応用 スカン 24 2.2.5

More information

溶血性尿毒症症候群 ver 最終.pptx

溶血性尿毒症症候群 ver 最終.pptx Hemolytic uremic syndrome(hus) ver0130525 (HUS), Stx VT 3 3 1. ( Hb10g/dl ) 2. ( 10 /µl ) 3. ( 97.5 ) 1.5 ) (HUS) D+HUS D-HUS(aHUS) HUS ahus ( 6 HUS ( ) HUS HUS ahus O-157 9-30 HUS 15 80 5 5 10 2-3 (O-157

More information

* ἅ ὅς 03 05(06) 0 ἄβιος,-ον, ἄβροτον ἄβροτος ἄβροτος,-ον, 08 17(01)-03 0 ἄβυσσος,-ου (ἡ), 08 17(01)-03 0 ἀβύσσου ἄβυ

* ἅ ὅς 03 05(06) 0 ἄβιος,-ον, ἄβροτον ἄβροτος ἄβροτος,-ον, 08 17(01)-03 0 ἄβυσσος,-ου (ἡ), 08 17(01)-03 0 ἀβύσσου ἄβυ Complete Ancient Greek 2010 (2003 ) October 15, 2013 * 25 04-23 0 ἅ ὅς 03 05(06) 0 ἄβιος,-ον, 15 99-02 0 ἄβροτον ἄβροτος 15 99-02 0 ἄβροτος,-ον, 08 17(01)-03 0 ἄβυσσος,-ου (ἡ), 08 17(01)-03 0 ἀβύσσου ἄβυσσος

More information

『共形場理論』

『共形場理論』 T (z) SL(2, C) T (z) SU(2) S 1 /Z 2 SU(2) (ŜU(2) k ŜU(2) 1)/ŜU(2) k+1 ŜU(2)/Û(1) G H N =1 N =1 N =1 N =1 N =2 N =2 N =2 N =2 ĉ>1 N =2 N =2 N =4 N =4 1 2 2 z=x 1 +ix 2 z f(z) f(z) 1 1 4 4 N =4 1 = = 1.3

More information

untitled

untitled CONTENTS 1 1 2 6 10 11 12 13 16 20 21 21 24 25 5381,150 86,939 23,350 28,052 36,121 20,719 30,379 35,841 86,939 87,523 1.3% 1.4% 1.5% 3.2% 2.2% 1.4% 3.0% 3.1% 3.6% 2014 4.5% 7.2% 5.3% 7.1% 13.9%.5% 15.2%

More information

第14〜15回 T細胞を介する免疫系.pptx

第14〜15回 T細胞を介する免疫系.pptx MBL CD8 CD4 8.1 8.2 5.20 8.3 8.4 8.5 8.6 8.7 8.8 8.9 8.10 8.18 B7 CD28 CD28 B7 CD28 8.13 2.22 NK Toll(TLR) LBP! LPS dsrna ssrna TLR1/2/6! TLR4 TLR5 TLR3 TLR7/9 CD14! JNK/p38! MyD88! IRAK! TRAF! NFκB! TNF-α

More information

RS5C313 Datasheet

RS5C313 Datasheet RS5C313 1 CE SCLK SIO VSS 1 2 3 4 8 7 6 5 VDD OSCIN OSCOUT INTR 2 3 Ω Ω µ µ µ µ 4 5 1 6 2 2.1 µ 7 µ µ µ 8 9 10 3 11 12 1 13 2 14 3 15 4 Ω Ω Ω 16 5 6 17 7 Ω 18 8 19 9 20 10 Ω µ VDD3V VDD5V VDD3V µ CG10pF

More information

202

202 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 DS =+α log (Spread )+ β DSRate +γlend +δ DEx DS t Spread t 1 DSRate t Lend t DEx DS DEx Spread DS

More information

たより214号

たより214号 1 162-0805 65 0352283171 FAX 0352283175 2 Towards Effective Anglican Ministry JOCS HIV 3 3 HIV Towards Effective Anglican Ministry (TEAM) HIV 2007 4 TEAM=Towards Effective Anglican Ministry 466-0034 5

More information

株式会社ナイスデイ | カタログ出力用

株式会社ナイスデイ | カタログ出力用 2014 2015 Autumn / Winter Collection 4,980 IN-FA-LA FOREST4571426662333 FOREST4571426662340 CIRCLE 4571426662319 CIRCLE 4571426662326 KULLE 4571426666782 KULLE 4571426666799 65%

More information

untitled

untitled 1 10 200 2 3 192 B1 PP PP PP PP NG PP 4 CM CM CM CM 20 NG PP PP 5 PP B B1 B1 B1 B B B 6 PP2010 3.5g 350 400 3.5 350 CM 350 PP8 15mmol 600 mmhg 15mmol 600mmHg mmhg PP PP 1 PP PP10 ACE ARB 7 ACE ACE 3.5g

More information

untitled

untitled NO.119 2014 11 28 http://www.i-nouryoku.com/index.html 0570-058-669 74 2 7 18 * 4 36ha 30 7.5ha 1 NO.119 2014 11 28 3.6ha 2.5ha * 20 2 122 2 籾 6.2ha 4 5 22ha6 7 55 6 8 15 8 9 9 10 1430 11 3 2 NO.119 2014

More information

1965( 40) * 1969( 44) 1996( 8) 5 * 1995( 7) 10 10 1997( 9) 10 1996( 8) 12 5 2000( 12) 12 2002 14 3

1965( 40) * 1969( 44) 1996( 8) 5 * 1995( 7) 10 10 1997( 9) 10 1996( 8) 12 5 2000( 12) 12 2002 14 3 1 20 1948( 23) 12 10 3 ( )* 1993( 5) 1994( 6) 1995( 7) 2004( 16) 10 10 10 * 1965( 40) * 1969( 44) 1996( 8) 5 * 1995( 7) 10 10 1997( 9) 10 1996( 8) 12 5 2000( 12) 12 2002 14 3 * 2003 15 10 2 HIV* * 1997(

More information